グルタミルアミノペプチダーゼのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Glutamyl Aminopeptidase Market Insights and Forecast to 2028

• レポートコード：QY2203B02638 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、72ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のグルタミルアミノペプチダーゼの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にグルタミルアミノペプチダーゼの世界市場のxxx％を占める「QGC-001」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「高血圧症」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のグルタミルアミノペプチダーゼの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのグルタミルアミノペプチダーゼ市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのグルタミルアミノペプチダーゼ市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 グルタミルアミノペプチダーゼのグローバル主要メーカーには、APAvadis Biotechnologies Srl、Quantum Genomics SAなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 グルタミルアミノペプチダーゼ市場は、種類と用途によって区分されます。世界のグルタミルアミノペプチダーゼ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 QGC-001、QGC-006、その他 【用途別セグメント】 高血圧症、うっ血性心不全、肝腫瘍、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - グルタミルアミノペプチダーゼ製品概要 - 種類別市場（QGC-001、QGC-006、その他） - 用途別市場（高血圧症、うっ血性心不全、肝腫瘍、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のグルタミルアミノペプチダーゼ販売量予測2017-2028 - 世界のグルタミルアミノペプチダーゼ売上予測2017-2028 - グルタミルアミノペプチダーゼの地域別販売量 - グルタミルアミノペプチダーゼの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別グルタミルアミノペプチダーゼ販売量 - 主要メーカー別グルタミルアミノペプチダーゼ売上 - 主要メーカー別グルタミルアミノペプチダーゼ価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（QGC-001、QGC-006、その他） - グルタミルアミノペプチダーゼの種類別販売量 - グルタミルアミノペプチダーゼの種類別売上 - グルタミルアミノペプチダーゼの種類別価格 ・用途別市場規模（高血圧症、うっ血性心不全、肝腫瘍、その他） - グルタミルアミノペプチダーゼの用途別販売量 - グルタミルアミノペプチダーゼの用途別売上 - グルタミルアミノペプチダーゼの用途別価格 ・北米市場 - 北米のグルタミルアミノペプチダーゼ市場規模（種類別、用途別） - 主要国別のグルタミルアミノペプチダーゼ市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのグルタミルアミノペプチダーゼ市場規模（種類別、用途別） - 主要国別のグルタミルアミノペプチダーゼ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のグルタミルアミノペプチダーゼ市場規模（種類別、用途別） - 主要国別のグルタミルアミノペプチダーゼ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のグルタミルアミノペプチダーゼ市場規模（種類別、用途別） - 主要国別のグルタミルアミノペプチダーゼ市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのグルタミルアミノペプチダーゼ市場規模（種類別、用途別） - 主要国別のグルタミルアミノペプチダーゼ市場規模（トルコ、サウジアラビア） ・企業情報 APAvadis Biotechnologies Srl、Quantum Genomics SA ・産業チェーン及び販売チャネル分析 - グルタミルアミノペプチダーゼの産業チェーン分析 - グルタミルアミノペプチダーゼの原材料 - グルタミルアミノペプチダーゼの生産プロセス - グルタミルアミノペプチダーゼの販売及びマーケティング - グルタミルアミノペプチダーゼの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - グルタミルアミノペプチダーゼの産業動向 - グルタミルアミノペプチダーゼのマーケットドライバー - グルタミルアミノペプチダーゼの課題 - グルタミルアミノペプチダーゼの阻害要因 ・主な調査結果

Market Analysis and Insights: Global Glutamyl Aminopeptidase Market
Due to the COVID-19 pandemic, the global Glutamyl Aminopeptidase market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, QGC-001 accounting for % of the Glutamyl Aminopeptidase global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hypertension segment is altered to an % CAGR throughout this forecast period.
China Glutamyl Aminopeptidase market size is valued at US$ million in 2021, while the US and Europe Glutamyl Aminopeptidase are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Glutamyl Aminopeptidase landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Glutamyl Aminopeptidase include APAvadis Biotechnologies Srl and Quantum Genomics SA etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Glutamyl Aminopeptidase Scope and Segment
Glutamyl Aminopeptidase market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Glutamyl Aminopeptidase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
QGC-001
QGC-006
Others
Segment by Application
Hypertension
Congestive Heart Failure
Hepatic Tumor
Others
By Company
APAvadis Biotechnologies Srl
Quantum Genomics SA
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

---

1 Study Coverage
1.1 Glutamyl Aminopeptidase Product Introduction
1.2 Market by Type
1.2.1 Global Glutamyl Aminopeptidase Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 QGC-001
1.2.3 QGC-006
1.2.4 Others
1.3 Market by Application
1.3.1 Global Glutamyl Aminopeptidase Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hypertension
1.3.3 Congestive Heart Failure
1.3.4 Hepatic Tumor
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Glutamyl Aminopeptidase Sales Estimates and Forecasts 2017-2028
2.2 Global Glutamyl Aminopeptidase Revenue Estimates and Forecasts 2017-2028
2.3 Global Glutamyl Aminopeptidase Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Glutamyl Aminopeptidase Sales by Region
2.4.1 Global Glutamyl Aminopeptidase Sales by Region (2017-2022)
2.4.2 Global Sales Glutamyl Aminopeptidase by Region (2023-2028)
2.5 Global Glutamyl Aminopeptidase Revenue by Region
2.5.1 Global Glutamyl Aminopeptidase Revenue by Region (2017-2022)
2.5.2 Global Glutamyl Aminopeptidase Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Glutamyl Aminopeptidase Sales by Manufacturers
3.1.1 Global Top Glutamyl Aminopeptidase Manufacturers by Sales (2017-2022)
3.1.2 Global Glutamyl Aminopeptidase Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Glutamyl Aminopeptidase in 2021
3.2 Global Glutamyl Aminopeptidase Revenue by Manufacturers
3.2.1 Global Glutamyl Aminopeptidase Revenue by Manufacturers (2017-2022)
3.2.2 Global Glutamyl Aminopeptidase Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Glutamyl Aminopeptidase Revenue in 2021
3.3 Global Glutamyl Aminopeptidase Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Glutamyl Aminopeptidase Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Glutamyl Aminopeptidase Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Glutamyl Aminopeptidase Sales by Type
4.1.1 Global Glutamyl Aminopeptidase Historical Sales by Type (2017-2022)
4.1.2 Global Glutamyl Aminopeptidase Forecasted Sales by Type (2023-2028)
4.1.3 Global Glutamyl Aminopeptidase Sales Market Share by Type (2017-2028)
4.2 Global Glutamyl Aminopeptidase Revenue by Type
4.2.1 Global Glutamyl Aminopeptidase Historical Revenue by Type (2017-2022)
4.2.2 Global Glutamyl Aminopeptidase Forecasted Revenue by Type (2023-2028)
4.2.3 Global Glutamyl Aminopeptidase Revenue Market Share by Type (2017-2028)
4.3 Global Glutamyl Aminopeptidase Price by Type
4.3.1 Global Glutamyl Aminopeptidase Price by Type (2017-2022)
4.3.2 Global Glutamyl Aminopeptidase Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Glutamyl Aminopeptidase Sales by Application
5.1.1 Global Glutamyl Aminopeptidase Historical Sales by Application (2017-2022)
5.1.2 Global Glutamyl Aminopeptidase Forecasted Sales by Application (2023-2028)
5.1.3 Global Glutamyl Aminopeptidase Sales Market Share by Application (2017-2028)
5.2 Global Glutamyl Aminopeptidase Revenue by Application
5.2.1 Global Glutamyl Aminopeptidase Historical Revenue by Application (2017-2022)
5.2.2 Global Glutamyl Aminopeptidase Forecasted Revenue by Application (2023-2028)
5.2.3 Global Glutamyl Aminopeptidase Revenue Market Share by Application (2017-2028)
5.3 Global Glutamyl Aminopeptidase Price by Application
5.3.1 Global Glutamyl Aminopeptidase Price by Application (2017-2022)
5.3.2 Global Glutamyl Aminopeptidase Price Forecast by Application (2023-2028)
6 North America
6.1 North America Glutamyl Aminopeptidase Market Size by Type
6.1.1 North America Glutamyl Aminopeptidase Sales by Type (2017-2028)
6.1.2 North America Glutamyl Aminopeptidase Revenue by Type (2017-2028)
6.2 North America Glutamyl Aminopeptidase Market Size by Application
6.2.1 North America Glutamyl Aminopeptidase Sales by Application (2017-2028)
6.2.2 North America Glutamyl Aminopeptidase Revenue by Application (2017-2028)
6.3 North America Glutamyl Aminopeptidase Market Size by Country
6.3.1 North America Glutamyl Aminopeptidase Sales by Country (2017-2028)
6.3.2 North America Glutamyl Aminopeptidase Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Glutamyl Aminopeptidase Market Size by Type
7.1.1 Europe Glutamyl Aminopeptidase Sales by Type (2017-2028)
7.1.2 Europe Glutamyl Aminopeptidase Revenue by Type (2017-2028)
7.2 Europe Glutamyl Aminopeptidase Market Size by Application
7.2.1 Europe Glutamyl Aminopeptidase Sales by Application (2017-2028)
7.2.2 Europe Glutamyl Aminopeptidase Revenue by Application (2017-2028)
7.3 Europe Glutamyl Aminopeptidase Market Size by Country
7.3.1 Europe Glutamyl Aminopeptidase Sales by Country (2017-2028)
7.3.2 Europe Glutamyl Aminopeptidase Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Glutamyl Aminopeptidase Market Size by Type
8.1.1 Asia Pacific Glutamyl Aminopeptidase Sales by Type (2017-2028)
8.1.2 Asia Pacific Glutamyl Aminopeptidase Revenue by Type (2017-2028)
8.2 Asia Pacific Glutamyl Aminopeptidase Market Size by Application
8.2.1 Asia Pacific Glutamyl Aminopeptidase Sales by Application (2017-2028)
8.2.2 Asia Pacific Glutamyl Aminopeptidase Revenue by Application (2017-2028)
8.3 Asia Pacific Glutamyl Aminopeptidase Market Size by Region
8.3.1 Asia Pacific Glutamyl Aminopeptidase Sales by Region (2017-2028)
8.3.2 Asia Pacific Glutamyl Aminopeptidase Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Glutamyl Aminopeptidase Market Size by Type
9.1.1 Latin America Glutamyl Aminopeptidase Sales by Type (2017-2028)
9.1.2 Latin America Glutamyl Aminopeptidase Revenue by Type (2017-2028)
9.2 Latin America Glutamyl Aminopeptidase Market Size by Application
9.2.1 Latin America Glutamyl Aminopeptidase Sales by Application (2017-2028)
9.2.2 Latin America Glutamyl Aminopeptidase Revenue by Application (2017-2028)
9.3 Latin America Glutamyl Aminopeptidase Market Size by Country
9.3.1 Latin America Glutamyl Aminopeptidase Sales by Country (2017-2028)
9.3.2 Latin America Glutamyl Aminopeptidase Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Glutamyl Aminopeptidase Market Size by Type
10.1.1 Middle East and Africa Glutamyl Aminopeptidase Sales by Type (2017-2028)
10.1.2 Middle East and Africa Glutamyl Aminopeptidase Revenue by Type (2017-2028)
10.2 Middle East and Africa Glutamyl Aminopeptidase Market Size by Application
10.2.1 Middle East and Africa Glutamyl Aminopeptidase Sales by Application (2017-2028)
10.2.2 Middle East and Africa Glutamyl Aminopeptidase Revenue by Application (2017-2028)
10.3 Middle East and Africa Glutamyl Aminopeptidase Market Size by Country
10.3.1 Middle East and Africa Glutamyl Aminopeptidase Sales by Country (2017-2028)
10.3.2 Middle East and Africa Glutamyl Aminopeptidase Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 APAvadis Biotechnologies Srl
11.1.1 APAvadis Biotechnologies Srl Corporation Information
11.1.2 APAvadis Biotechnologies Srl Overview
11.1.3 APAvadis Biotechnologies Srl Glutamyl Aminopeptidase Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 APAvadis Biotechnologies Srl Glutamyl Aminopeptidase Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 APAvadis Biotechnologies Srl Recent Developments
11.2 Quantum Genomics SA
11.2.1 Quantum Genomics SA Corporation Information
11.2.2 Quantum Genomics SA Overview
11.2.3 Quantum Genomics SA Glutamyl Aminopeptidase Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Quantum Genomics SA Glutamyl Aminopeptidase Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Quantum Genomics SA Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Glutamyl Aminopeptidase Industry Chain Analysis
12.2 Glutamyl Aminopeptidase Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Glutamyl Aminopeptidase Production Mode & Process
12.4 Glutamyl Aminopeptidase Sales and Marketing
12.4.1 Glutamyl Aminopeptidase Sales Channels
12.4.2 Glutamyl Aminopeptidase Distributors
12.5 Glutamyl Aminopeptidase Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Glutamyl Aminopeptidase Industry Trends
13.2 Glutamyl Aminopeptidase Market Drivers
13.3 Glutamyl Aminopeptidase Market Challenges
13.4 Glutamyl Aminopeptidase Market Restraints
14 Key Findings in The Global Glutamyl Aminopeptidase Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Glutamyl Aminopeptidase Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of QGC-001
Table 3. Major Manufacturers of QGC-006
Table 4. Major Manufacturers of Others
Table 5. Global Glutamyl Aminopeptidase Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Glutamyl Aminopeptidase Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Glutamyl Aminopeptidase Sales by Region (2017-2022) & (K Pcs)
Table 8. Global Glutamyl Aminopeptidase Sales Market Share by Region (2017-2022)
Table 9. Global Glutamyl Aminopeptidase Sales by Region (2023-2028) & (K Pcs)
Table 10. Global Glutamyl Aminopeptidase Sales Market Share by Region (2023-2028)
Table 11. Global Glutamyl Aminopeptidase Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Glutamyl Aminopeptidase Revenue Market Share by Region (2017-2022)
Table 13. Global Glutamyl Aminopeptidase Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Glutamyl Aminopeptidase Revenue Market Share by Region (2023-2028)
Table 15. Global Glutamyl Aminopeptidase Sales by Manufacturers (2017-2022) & (K Pcs)
Table 16. Global Glutamyl Aminopeptidase Sales Share by Manufacturers (2017-2022)
Table 17. Global Glutamyl Aminopeptidase Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Glutamyl Aminopeptidase Revenue Share by Manufacturers (2017-2022)
Table 19. Glutamyl Aminopeptidase Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 20. Global Glutamyl Aminopeptidase Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Glutamyl Aminopeptidase by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glutamyl Aminopeptidase as of 2021)
Table 22. Glutamyl Aminopeptidase Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Glutamyl Aminopeptidase Product Offered
Table 24. Date of Manufacturers Enter into Glutamyl Aminopeptidase Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Glutamyl Aminopeptidase Sales by Type (2017-2022) & (K Pcs)
Table 27. Global Glutamyl Aminopeptidase Sales by Type (2023-2028) & (K Pcs)
Table 28. Global Glutamyl Aminopeptidase Sales Share by Type (2017-2022)
Table 29. Global Glutamyl Aminopeptidase Sales Share by Type (2023-2028)
Table 30. Global Glutamyl Aminopeptidase Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Glutamyl Aminopeptidase Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Glutamyl Aminopeptidase Revenue Share by Type (2017-2022)
Table 33. Global Glutamyl Aminopeptidase Revenue Share by Type (2023-2028)
Table 34. Glutamyl Aminopeptidase Price by Type (2017-2022) & (USD/Pcs)
Table 35. Global Glutamyl Aminopeptidase Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 36. Global Glutamyl Aminopeptidase Sales by Application (2017-2022) & (K Pcs)
Table 37. Global Glutamyl Aminopeptidase Sales by Application (2023-2028) & (K Pcs)
Table 38. Global Glutamyl Aminopeptidase Sales Share by Application (2017-2022)
Table 39. Global Glutamyl Aminopeptidase Sales Share by Application (2023-2028)
Table 40. Global Glutamyl Aminopeptidase Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Glutamyl Aminopeptidase Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Glutamyl Aminopeptidase Revenue Share by Application (2017-2022)
Table 43. Global Glutamyl Aminopeptidase Revenue Share by Application (2023-2028)
Table 44. Glutamyl Aminopeptidase Price by Application (2017-2022) & (USD/Pcs)
Table 45. Global Glutamyl Aminopeptidase Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 46. North America Glutamyl Aminopeptidase Sales by Type (2017-2022) & (K Pcs)
Table 47. North America Glutamyl Aminopeptidase Sales by Type (2023-2028) & (K Pcs)
Table 48. North America Glutamyl Aminopeptidase Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Glutamyl Aminopeptidase Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Glutamyl Aminopeptidase Sales by Application (2017-2022) & (K Pcs)
Table 51. North America Glutamyl Aminopeptidase Sales by Application (2023-2028) & (K Pcs)
Table 52. North America Glutamyl Aminopeptidase Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Glutamyl Aminopeptidase Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Glutamyl Aminopeptidase Sales by Country (2017-2022) & (K Pcs)
Table 55. North America Glutamyl Aminopeptidase Sales by Country (2023-2028) & (K Pcs)
Table 56. North America Glutamyl Aminopeptidase Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Glutamyl Aminopeptidase Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Glutamyl Aminopeptidase Sales by Type (2017-2022) & (K Pcs)
Table 59. Europe Glutamyl Aminopeptidase Sales by Type (2023-2028) & (K Pcs)
Table 60. Europe Glutamyl Aminopeptidase Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Glutamyl Aminopeptidase Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Glutamyl Aminopeptidase Sales by Application (2017-2022) & (K Pcs)
Table 63. Europe Glutamyl Aminopeptidase Sales by Application (2023-2028) & (K Pcs)
Table 64. Europe Glutamyl Aminopeptidase Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Glutamyl Aminopeptidase Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Glutamyl Aminopeptidase Sales by Country (2017-2022) & (K Pcs)
Table 67. Europe Glutamyl Aminopeptidase Sales by Country (2023-2028) & (K Pcs)
Table 68. Europe Glutamyl Aminopeptidase Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Glutamyl Aminopeptidase Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Glutamyl Aminopeptidase Sales by Type (2017-2022) & (K Pcs)
Table 71. Asia Pacific Glutamyl Aminopeptidase Sales by Type (2023-2028) & (K Pcs)
Table 72. Asia Pacific Glutamyl Aminopeptidase Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Glutamyl Aminopeptidase Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Glutamyl Aminopeptidase Sales by Application (2017-2022) & (K Pcs)
Table 75. Asia Pacific Glutamyl Aminopeptidase Sales by Application (2023-2028) & (K Pcs)
Table 76. Asia Pacific Glutamyl Aminopeptidase Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Glutamyl Aminopeptidase Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Glutamyl Aminopeptidase Sales by Region (2017-2022) & (K Pcs)
Table 79. Asia Pacific Glutamyl Aminopeptidase Sales by Region (2023-2028) & (K Pcs)
Table 80. Asia Pacific Glutamyl Aminopeptidase Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Glutamyl Aminopeptidase Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Glutamyl Aminopeptidase Sales by Type (2017-2022) & (K Pcs)
Table 83. Latin America Glutamyl Aminopeptidase Sales by Type (2023-2028) & (K Pcs)
Table 84. Latin America Glutamyl Aminopeptidase Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Glutamyl Aminopeptidase Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Glutamyl Aminopeptidase Sales by Application (2017-2022) & (K Pcs)
Table 87. Latin America Glutamyl Aminopeptidase Sales by Application (2023-2028) & (K Pcs)
Table 88. Latin America Glutamyl Aminopeptidase Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Glutamyl Aminopeptidase Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Glutamyl Aminopeptidase Sales by Country (2017-2022) & (K Pcs)
Table 91. Latin America Glutamyl Aminopeptidase Sales by Country (2023-2028) & (K Pcs)
Table 92. Latin America Glutamyl Aminopeptidase Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Glutamyl Aminopeptidase Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Glutamyl Aminopeptidase Sales by Type (2017-2022) & (K Pcs)
Table 95. Middle East and Africa Glutamyl Aminopeptidase Sales by Type (2023-2028) & (K Pcs)
Table 96. Middle East and Africa Glutamyl Aminopeptidase Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Glutamyl Aminopeptidase Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Glutamyl Aminopeptidase Sales by Application (2017-2022) & (K Pcs)
Table 99. Middle East and Africa Glutamyl Aminopeptidase Sales by Application (2023-2028) & (K Pcs)
Table 100. Middle East and Africa Glutamyl Aminopeptidase Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Glutamyl Aminopeptidase Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Glutamyl Aminopeptidase Sales by Country (2017-2022) & (K Pcs)
Table 103. Middle East and Africa Glutamyl Aminopeptidase Sales by Country (2023-2028) & (K Pcs)
Table 104. Middle East and Africa Glutamyl Aminopeptidase Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Glutamyl Aminopeptidase Revenue by Country (2023-2028) & (US$ Million)
Table 106. APAvadis Biotechnologies Srl Corporation Information
Table 107. APAvadis Biotechnologies Srl Description and Major Businesses
Table 108. APAvadis Biotechnologies Srl Glutamyl Aminopeptidase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 109. APAvadis Biotechnologies Srl Glutamyl Aminopeptidase Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. APAvadis Biotechnologies Srl Recent Developments
Table 111. Quantum Genomics SA Corporation Information
Table 112. Quantum Genomics SA Description and Major Businesses
Table 113. Quantum Genomics SA Glutamyl Aminopeptidase Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 114. Quantum Genomics SA Glutamyl Aminopeptidase Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Quantum Genomics SA Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Glutamyl Aminopeptidase Distributors List
Table 119. Glutamyl Aminopeptidase Customers List
Table 120. Glutamyl Aminopeptidase Market Trends
Table 121. Glutamyl Aminopeptidase Market Drivers
Table 122. Glutamyl Aminopeptidase Market Challenges
Table 123. Glutamyl Aminopeptidase Market Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Glutamyl Aminopeptidase Product Picture
Figure 3. Global Glutamyl Aminopeptidase Market Share by Type in 2021 & 2028
Figure 3. QGC-001 Product Picture
Figure 4. QGC-006 Product Picture
Figure 5. Others Product Picture
Figure 6. Global Glutamyl Aminopeptidase Market Share by Application in 2021 & 2028
Figure 7. Hypertension
Figure 8. Congestive Heart Failure
Figure 9. Hepatic Tumor
Figure 10. Others
Figure 11. Glutamyl Aminopeptidase Report Years Considered
Figure 12. Global Glutamyl Aminopeptidase Sales 2017-2028 (K Pcs)
Figure 13. Global Glutamyl Aminopeptidase Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Glutamyl Aminopeptidase Revenue 2017-2028 (US$ Million)
Figure 15. Global Glutamyl Aminopeptidase Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Glutamyl Aminopeptidase Sales Market Share by Region (2017-2022)
Figure 17. Global Glutamyl Aminopeptidase Sales Market Share by Region (2023-2028)
Figure 18. North America Glutamyl Aminopeptidase Sales YoY (2017-2028) & (K Pcs)
Figure 19. North America Glutamyl Aminopeptidase Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Glutamyl Aminopeptidase Sales YoY (2017-2028) & (K Pcs)
Figure 21. Europe Glutamyl Aminopeptidase Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Glutamyl Aminopeptidase Sales YoY (2017-2028) & (K Pcs)
Figure 23. Asia-Pacific Glutamyl Aminopeptidase Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Glutamyl Aminopeptidase Sales YoY (2017-2028) & (K Pcs)
Figure 25. Latin America Glutamyl Aminopeptidase Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Glutamyl Aminopeptidase Sales YoY (2017-2028) & (K Pcs)
Figure 27. Middle East & Africa Glutamyl Aminopeptidase Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Glutamyl Aminopeptidase Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Glutamyl Aminopeptidase in the World: Market Share by Glutamyl Aminopeptidase Revenue in 2021
Figure 30. Global Glutamyl Aminopeptidase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Glutamyl Aminopeptidase Sales Market Share by Type (2017-2028)
Figure 32. Global Glutamyl Aminopeptidase Revenue Market Share by Type (2017-2028)
Figure 33. Global Glutamyl Aminopeptidase Sales Market Share by Application (2017-2028)
Figure 34. Global Glutamyl Aminopeptidase Revenue Market Share by Application (2017-2028)
Figure 35. North America Glutamyl Aminopeptidase Sales Market Share by Type (2017-2028)
Figure 36. North America Glutamyl Aminopeptidase Revenue Market Share by Type (2017-2028)
Figure 37. North America Glutamyl Aminopeptidase Sales Market Share by Application (2017-2028)
Figure 38. North America Glutamyl Aminopeptidase Revenue Market Share by Application (2017-2028)
Figure 39. North America Glutamyl Aminopeptidase Sales Share by Country (2017-2028)
Figure 40. North America Glutamyl Aminopeptidase Revenue Share by Country (2017-2028)
Figure 41. U.S. Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Glutamyl Aminopeptidase Sales Market Share by Type (2017-2028)
Figure 44. Europe Glutamyl Aminopeptidase Revenue Market Share by Type (2017-2028)
Figure 45. Europe Glutamyl Aminopeptidase Sales Market Share by Application (2017-2028)
Figure 46. Europe Glutamyl Aminopeptidase Revenue Market Share by Application (2017-2028)
Figure 47. Europe Glutamyl Aminopeptidase Sales Share by Country (2017-2028)
Figure 48. Europe Glutamyl Aminopeptidase Revenue Share by Country (2017-2028)
Figure 49. Germany Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 50. France Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Glutamyl Aminopeptidase Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Glutamyl Aminopeptidase Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Glutamyl Aminopeptidase Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Glutamyl Aminopeptidase Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Glutamyl Aminopeptidase Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Glutamyl Aminopeptidase Revenue Share by Region (2017-2028)
Figure 60. China Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 63. India Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Glutamyl Aminopeptidase Sales Market Share by Type (2017-2028)
Figure 71. Latin America Glutamyl Aminopeptidase Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Glutamyl Aminopeptidase Sales Market Share by Application (2017-2028)
Figure 73. Latin America Glutamyl Aminopeptidase Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Glutamyl Aminopeptidase Sales Share by Country (2017-2028)
Figure 75. Latin America Glutamyl Aminopeptidase Revenue Share by Country (2017-2028)
Figure 76. Mexico Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Glutamyl Aminopeptidase Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Glutamyl Aminopeptidase Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Glutamyl Aminopeptidase Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Glutamyl Aminopeptidase Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Glutamyl Aminopeptidase Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Glutamyl Aminopeptidase Revenue Share by Country (2017-2028)
Figure 85. Turkey Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 87. U.A.E Glutamyl Aminopeptidase Revenue (2017-2028) & (US$ Million)
Figure 88. Glutamyl Aminopeptidase Value Chain
Figure 89. Glutamyl Aminopeptidase Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed

---